Caixin
Aug 15, 2021 08:00 AM

Changchun Bcht Biotechnology Co.,Ltd.’s Net Profit Dropped 23.1% in First Half of 2021

Changchun Bcht Biotechnology Co.,Ltd. (长春百克生物科技股份公司) (688276.SH) reported a net profit of 138.4 million yuan in the first half of 2021, down 23.1% year-on-year.

Meanwhile, the company posted 582.3 million yuan in revenue, down 3% year-on-year.

At the end of the reporting period, it had 4 billion yuan in total assets and 733.4 million yuan in total liabilities, with a liability-to-asset ratio of 18.1%.

This article was automatically produced by Caixin Automation on Aug. 26, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin Biz Roundup: China’s Covid Caseload Hits Six-Month High
00:00
00:00/00:00